Rahman Siamak
Department of Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1778, USA.
Am J Ther. 2009 Jul-Aug;16(4):300-3. doi: 10.1097/MJT.0b013e318183d549.
This article reviews certain aspects of venous thromboembolism, a major cause of morbidity and mortality among hospitalized patients. Deep vein thrombosis is a frequent complication of various surgical procedures. Knowing predisposing factors, including hereditary causes, and triggering risk factors will help us identify patients with high risk of venous thromboembolism. The prophylaxis recommendations by American College of Chest Physicians are made for groups of patients, for whom the benefits seem to outweigh the risks. However, those readers who want to adopt the American College of Chest Physicians' guidelines in their practices are urged to review in detail the pharmacology of the drugs used for thromboprophylaxis, relevant clinical studies, and case reports of spinal hematoma. Each patient might have different risks for thrombosis or bleeding and the potential for adverse consequences due to the prophylaxis. What is best for the group (the epidemiologic perspective) is not necessarily what is best for the individual patient (the clinical perspective).
本文回顾了静脉血栓栓塞的某些方面,这是住院患者发病和死亡的主要原因。深静脉血栓形成是各种外科手术常见的并发症。了解包括遗传因素在内的易感因素和触发风险因素,将有助于我们识别静脉血栓栓塞高危患者。美国胸科医师学会针对受益似乎大于风险的患者群体提出了预防建议。然而,敦促那些希望在实践中采用美国胸科医师学会指南的读者详细查阅用于血栓预防的药物药理学、相关临床研究以及脊髓血肿的病例报告。每位患者发生血栓形成或出血的风险以及预防措施导致不良后果的可能性可能不同。对群体而言最佳的措施(从流行病学角度)不一定对个体患者也是最佳的(从临床角度)。